Endometrioid ovarian carcinomas carrying MMR and POLE alterations seem to represent a subgroup with favourable prognosis, while abnormal p53 indicates a worse prognosis [37,39]. This evidence concerns the gene TP53 and ovarian endometrioid carcinoma.